SUSAN BALTZ: Open Payments
NPI 1992919484 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 12 payments from 9 companies in 2025. Trend: 2023 $1,500 · 2024 $1,593 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $370 |
| Phathom Pharmaceuticals, Inc. | 2 | $172 |
| Madrigal Pharmaceuticals | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $125 |
| Astellas Pharma US Inc | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $112 |
| KYOWA KIRIN, INC. | 1 | $110 |
| Abbott Laboratories | 1 | $56 |
Products named: BREZTRI, VOQUEZNA, REZDIFFRA, Kerendia, Veozah, REXULTI, AIRSUPRA, Wegovy.
Industry payments across TX — which companies pay providers there.
